Company profile for Agenus

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Agenus is an immuno-oncology company designed to deliver innovation with speed for patients with cancer. We have a unique portfolio of antibodies, vaccines, cell therapies (through our AgenTus Therapeutics subsidiary) and adjuvants designed to treat cancers with optimal combinations. In addition to our broad portfolio, we have an accomplished team of scientists, novel technology platforms and end-to-end capabilities from new t...
Agenus is an immuno-oncology company designed to deliver innovation with speed for patients with cancer. We have a unique portfolio of antibodies, vaccines, cell therapies (through our AgenTus Therapeutics subsidiary) and adjuvants designed to treat cancers with optimal combinations. In addition to our broad portfolio, we have an accomplished team of scientists, novel technology platforms and end-to-end capabilities from new target discovery to GMP manufacturing.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
3 Forbes Road Lexington, MA 02421-7305
Telephone
Telephone
781.674.4400
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20260121295490/en/Agenus-Expands-Medical-Affairs-Infrastructure-to-Support-Increasing-Physician-Requests-for-Authorized-Access-to-Botensilimab-Plus-Balstilimab

BUSINESSWIRE
21 Jan 2026

https://www.businesswire.com/news/home/20260120995688/en/Agenus-to-Host-First-2026-Stakeholder-Webcast

BUSINESSWIRE
20 Jan 2026

https://www.prnewswire.com/news-releases/zydus-lifesciences-limited-completes-the-acquisition-of-agenus-incs-biologics-manufacturing-facilities-launches-zylidac-bio-llc-in-the-us-302662438.html

PR NEWSWIRE
15 Jan 2026

https://www.businesswire.com/news/home/20251223989276/en/Agenus-Reports-Deep-Durable-Responses-with-Botensilimab-Balstilimab-in-Highly-Refractory-Ovarian-Cancer-Published-in-JITC

BUSINESSWIRE
23 Dec 2025

https://www.businesswire.com/news/home/20251119991532/en/Agenus-to-Host-End-of-Year-Stakeholder-Webcast-Featuring-GI-Oncology-Leaders-and-Progress-of-BOTBAL

BUSINESSWIRE
19 Nov 2025

https://www.businesswire.com/news/home/20251118089134/en/Agenus-Appoints-Dr.-Jos-Iglesias-as-Chief-Medical-Affairs-Officer-to-Guide-Global-Medical-Affairs-and-Early-Access-Programs-Including-Frances-AAC

BUSINESSWIRE
18 Nov 2025

Inspections and registrations

Upload your audits for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty